Book a Meeting

Fc Engineered Anti-Human CD20 Therapeutic Antibody, a CDC-Enhanced Biobetter [Lot: CB20-PZ48] (CAT#: BioBet-C048ZP) Datasheet

Target
CD20
Isotype
Whole Human Antibody
Description
CDC-Enhanced Ocrelizumab is a Fc-modified anti-CD20 therapeutic biobetter antibody. Creative Biolabs' advanced CDC-enhanced antibody platform allows for the production of Fc engineered therapeutic CDC⁺ antibodies. By mutating key amino acids of the Fc region of Ocrelizumab, Ocrelizumab exhibits a greater binding capacity to C1q, thereby achieving enhanced CDC activity.
Indication
Multiple sclerosis
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced rituximab. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
MS4A1
Full Name
membrane spanning 4-domains A1
Background
This gene encodes a member of the membranespanning 4A gene family. Members of this nascent protein family are characterized by common structural features and similar intron/exon splice boundaries and display unique expression patterns among hematopoietic cells and nonlymphoid tissues. This gene encodes a Blymphocyte surface molecule which plays a role in the development and differentiation of Bcells into plasma cells. This family member is localized to 11q12, among a cluster of family members. Alternative splicing of this gene results in two transcript variants which encode the same protein.
Gene ID
931
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
Humanized IgG1
Indication
Multiple Sclerosis, Primary Progressive
Relapsing Multiple Sclerosis (RMS)

Multiple Sclerosis, Primary Progressive
Relapsing Multiple Sclerosis (RMS)

Related Products

Fc Engineered Anti-Human CD20 Therapeutic Antibody, a CDC-Enhanced Biobetter [Lot: CB20-PZ03] (CAT#: BioBet-C003ZP)
Fc Engineered Anti-Human CD20 Therapeutic Antibody, a CDC-Enhanced Biobetter [Lot: CB20-PZ352] (CAT#: Biobet-C352ZP)
Fc Engineered Anti-Human CD20 Therapeutic Antibody, a CDC-Enhanced Biobetter [Lot: CB20-PZ353] (CAT#: Biobet-C353ZP)
Fc Engineered Anti-Human CD20 Antibody, CDC-Enhanced (CAT#: BioBet-C029ZP)
Fc Engineered Anti-Human CD20 Therapeutic Antibody, a CDC-Enhanced Biobetter [Lot: CB20-PZ349] (CAT#: Biobet-C349ZP)
Fc Engineered Anti-Human CD20 Therapeutic Antibody, a CDC-Enhanced Biobetter [Lot: CB20-PZ350] (CAT#: Biobet-C350ZP)
Fc Engineered Anti-Human CD20 Therapeutic Antibody, a CDC-Enhanced Biobetter [Lot: CB20-PZ351] (CAT#: Biobet-C351ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.